Biological monitoring of occupational exposure to contraceptive drugs

Industrial Health

Volumn 34, Issue 3, 1996, Pages 267-277

  Shamy, Magdy Youssef ^a   Soliman, Osama El Sayed ^a   Osman, Hassan Ahmed ^a   El Gazzar, Ragaa Mohammed ^a  

^a High Institute of Public Health Egypt   (Egypt)

Author keywords

Contraceptive drugs; Gonadotropins; Lipid profile; Liver function; Sex hormones

Indexed keywords

ADULT; ARTICLE; BLOOD CLOTTING; DRUG INDUSTRY; ENVIRONMENTAL EXPOSURE; FEMALE; HORMONAL CONTRACEPTION; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; LIVER FUNCTION; MALE; NORMAL HUMAN; OCCUPATIONAL SAFETY; RISK ASSESSMENT;

EID: 0030017014     PISSN: 00198366     EISSN: None     Source Type: Journal    
DOI: 10.2486/indhealth.34.267     Document Type: Article

References (27)

1. Harrington J, Stein G, Rivera R, de Morales A. The occupational hazards of formulating oral contraceptives. A survey of plant employees. Arch Environ Health 1978; 33: 12-5.
2. Vessey M, Doll R, Peto R. A long-term follow up study of women using different methods of contraception. An interim report. J Biosoc Sci 1976; 8: 373-427.
3. Hickey R, Clelland R, Bowers E. Essential hormones as carinogenic hazards. J Occup Med 1974; 21: 265-8.
4. Farina G, Alessio L, Bandral S. L'esposizione professionals a farmaci: Ormoni. Med Lav 1977; 68: 105-13.
5. El Samra G, El Safty A, Siha M, Fathy A. Breast changes in workers engaged in the manufacture of sex hormones. Egypt J Occup Med 1992; 16: 237-44.
6. Sissin J. Handbook of clinical pathology. In: JB Lippincott G, eds. Philadelphia, 1976; 172-8.
7. Shimadzu flame atomic absorption manual. Standard analytical methods; 1990.
8. Egypt. Maternal and child health survey 1991. Farouk Abdel Azeem Samir Farid, Atef Khalifa. Pan Arab Project for Child Development 1993: 152.
9. Bayoumi S, Ayoub A, Khamis Y, Sobhi S. Determination of menopausal age among females attending the outpatient gynecology clinic in Al Shatby Hospital. Tanta Med J 1994; 22: 1337-49.
10. Willems H. Occupational exposure to estrogens and screening for health effects. J Occup Med 1981; 23: 813-6.
11. Gilman A, Goodman L, Oilman A. The pharmacological basis of therapeutics. In Boston G, eds. Mac Millan Publishing, 1980: 1450.
12. Robinson R, Higano N, Cohen W. Long-term effects of high-dose estrogen therapy in men with coronary heart disease. J Chronic Dis 1963; 16: 155-61.
13. Kulin H, Reiter E. Gonadotropin and testosterone measurement after estrogen administration to adult men, prepubertal and pubertal boys and men with hypogonadotropism. Evidence for maturation of positive feedback in the male. Pediatr Res 1976; 10: 46-51.
14. Franchimont P, Dourcy C, Legros J et al. Dosage de la prolactine dans les conditions nonnales et pathologiques. Ann Endocrinol (Paris) 1976; 37: 127-56.
15. Kulin H, Reiter E. Gonadotropin suppression by low dose estrogen in men: Evidence for differential effects upon FSH and LH. J Clin Endocrinol Metab 1972; 35: 836-9.
16. Walsh P, Swerdloff R, Odell W. Feedback control of FSH in the male the role of estrogen. Acta Endocrinol (Copenhgen) 1973; 74: 449-60.
17. Innerfield F. Enzymes in clinical chemistry. McGraw-Hill Publications, New York, 1960; 465-71.
18. Tiez N. Fundamentals of clinical chemistry. 3rd ed. Philadelphia: W B Saunders, 1987; 257-8.
19. Fikry A. Gastroentrology. Part I. El Maaref Establishment, Alexandria, 1978; 106-8.
20. Kalkhoff R. Metabolic effects of progesterone. Am J Obstet Gynecol 1982; 142: 735-9.
21. Poller L, Thompson J, Otridge B, Yee K, Logan S. Effects of manufacturing oral contraceptives on blood clotting. British Med J 1979; 1: 1761-2.
22. Spellacy W. Carbohydrate metabolism during treatment with estrogen, progesterone and low dose oral contraceptives. Am J Obstet Gynecol 1982; 142: 732-7.
23. Seed M, Godalands I, Wynn V, Jacobs J. The effects of cyproterone acetate and ethinyl estradiol on carbohydrate metabolism. Clin Endocrin 1984; 21: 689-94.
24. Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 1990; 12: 321-31.
25. Mathews K, Elaine M, Kuller I, Kelsey S, Cagguila A, Wing P. Menopausal and risk factors for coronary heart disease. N Engl J Med 1989; 321: 641-6.
26. Jensen J, Riis B, Storm V, Nilas I, Christiansen C. Longterm effects of percutanous estrogen and oral progesterone on serum lipoproteins in postmenopausal women. Am J Obstet Gynecol 1987; 156: 66-71.
27. Encyclopedia of occupational health and safety. International Labor Office. Geneva. 3rd revised ed. 1989; 1049-52.